Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

Similar articles for PubMed (Select 19189991)

1.

The effects of the coverage gap on drug spending: a closer look at Medicare Part D.

Zhang Y, Donohue JM, Newhouse JP, Lave JR.

Health Aff (Millwood). 2009 Mar-Apr;28(2):w317-25. doi: 10.1377/hlthaff.28.2.w317. Epub 2009 Feb 3.

2.
3.

Impact of cost sharing on prescription drugs used by Medicare beneficiaries.

Goedken AM, Urmie JM, Farris KB, Doucette WR.

Res Social Adm Pharm. 2010 Jun;6(2):100-9. doi: 10.1016/j.sapharm.2010.03.003. Epub 2010 May 7.

PMID:
20511109
4.

Beneficiaries with cardiovascular disease and thePart D coverage gap.

Polinski JM, Shrank WH, Glynn RJ, Huskamp HA, Roebuck MC, Schneeweiss S.

Circ Cardiovasc Qual Outcomes. 2012 May;5(3):387-95. doi: 10.1161/CIRCOUTCOMES.111.964866. Epub 2012 Apr 17.

5.

Assessment of drug consumption patterns for Medicare Part D patients.

Pedan A, Lu J, Varasteh LT.

Am J Manag Care. 2009 May;15(5):323-7.

6.

Falling into the coverage gap: Part D drug costs and adherence for Medicare Advantage prescription drug plan beneficiaries with diabetes.

Fung V, Mangione CM, Huang J, Turk N, Quiter ES, Schmittdiel JA, Hsu J.

Health Serv Res. 2010 Apr;45(2):355-75. doi: 10.1111/j.1475-6773.2009.01071.x. Epub 2009 Dec 30.

7.

Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase.

Park H, Rascati KL, Lawson KA, Barner JC, Richards KM, Malone DC.

J Manag Care Spec Pharm. 2014 Aug;20(8):862-76.

8.
9.

Changes in drug utilization during a gap in insurance coverage: an examination of the medicare Part D coverage gap.

Polinski JM, Shrank WH, Huskamp HA, Glynn RJ, Liberman JN, Schneeweiss S.

PLoS Med. 2011 Aug;8(8):e1001075. doi: 10.1371/journal.pmed.1001075. Epub 2011 Aug 16. Erratum in: PLoS Med. 2014 Aug;11(8):e1001716.

10.

Cost variability of suggested generic treatment alternatives under the Medicare Part D benefit.

Patel RA, Walberg MP, Tong E, Tan F, Rummel AE, Woelfel JA, Carr-Lopez SM, Galal SM.

J Manag Care Spec Pharm. 2014 Mar;20(3):283-90.

11.
12.

Impact of multitiered copayments on the use and cost of prescription drugs among Medicare beneficiaries.

Gilman BH, Kautter J.

Health Serv Res. 2008 Apr;43(2):478-95. doi: 10.1111/j.1475-6773.2007.00774.x.

13.

Providing prescription drug coverage to the elderly: America's experiment with Medicare Part D.

Duggan M, Healy P, Morton FS.

J Econ Perspect. 2008 Fall;22(4):69-92. No abstract available.

PMID:
19768843
15.

Digesting the doughnut hole.

Joyce GF, Zissimopoulos J, Goldman DP.

J Health Econ. 2013 Dec;32(6):1345-55. doi: 10.1016/j.jhealeco.2013.04.007. Epub 2013 May 6.

16.

The effect of Medicare Part D on drug and medical spending.

Zhang Y, Donohue JM, Lave JR, O'Donnell G, Newhouse JP.

N Engl J Med. 2009 Jul 2;361(1):52-61. doi: 10.1056/NEJMsa0807998.

17.

Trends in the prescription drug plans delivering the Medicare Part D prescription drug benefit.

Brill JV.

Am J Health Syst Pharm. 2007 Aug 1;64(15 Suppl 10):S3-6; quiz S21-S23. Review.

PMID:
17646551
18.

Medicare prescription drug plan coverage of pharmacotherapies for opioid and alcohol dependence in WA.

Kennedy J, Dipzinski A, Roll J, Coyne J, Blodgett E.

Drug Alcohol Depend. 2011 Apr 1;114(2-3):201-6. doi: 10.1016/j.drugalcdep.2010.08.016. Epub 2010 Dec 4.

PMID:
21134724
19.

Supplemental coverage associated with more rapid spending growth for Medicare beneficiaries.

Golberstein E, Walsh K, He Y, Chernew ME.

Health Aff (Millwood). 2013 May;32(5):873-81. doi: 10.1377/hlthaff.2012.1230.

20.

Insurance coverage for prescription drugs: effects on use and expenditures in the Medicare population.

Lillard LA, Rogowski J, Kington R.

Med Care. 1999 Sep;37(9):926-36.

PMID:
10493470
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk